National Bulk Purchasing Strategy: Enhancing Dr...

By Staff Writer

July 16, 2025

A national bulk purchasing strategy is emerging as a crucial solution for Canada’s prescription drug system. How could this approach impact affordability, access, and the long-term stability of pharmacare in Canada? Canada’s Drug Agency (CDA) has ...
Silencing Science Impact: Political Interference and Global Health Consequences
Caution Advised: Conflicts in AAP Childhood Obesity Guidelines
T1 Diabetes Care with an Implantable Glucose Device
Federated Learning Governance in Healthcare: A Framework for Ethical and Effe...
Masitinib Prostate Cancer Trial Gains FDA and EMA Approval for Phase 3 Study
Ticagrelor Data Integrity Under Fire: Scrutiny Reveals Flaws in Key Clinical ...
Impending Net Drug Price Transparency Regulation in the U.S.
Canada Launches Consultation for Essential Prescription Drugs List
ACIP Vaccine Policy Concerns
Efficacy of Ultomiris Pediatric TMA Treatment
KEYTRUDA Head Neck Cancer Approval: Transforming Treatment and Health Economics
Mavyret Acute Hepatitis C: Pioneering Treatment Expansion and Economic Implic...